We are international

This is an invitation-only meeting devoted exclusively to hematologists and oncologists that treat myeloma. It is a unique opportunity for these physicians to receive feedback from experienced hematologists and oncologists related to how they deal with myeloma treatments across the country. The participating audience will be able to share their thoughts about their own patients' care, but also have the opportunity to debate particular treatment recommendations of the discussant leaders.

Discussant Leaders
Most of the six are members of the International Myeloma Foundation Scientific Advisors Board:

  • Dr. Robert Kyle*, Mayo Clinic and Chairman of the IMF Scientific Advisors Board
  • Dr. Raymond Alexanian*, M.D. Anderson Cancer Center, Houston, TX
  • Dr. Bart Barlogie*, University of Arkansas Medical Sciences Center, Little Rock, AR
  • Dr. Bill Bensinger*, Fred Hutchinson Cancer Research Center, Seattle, WA
  • Dr. Sundar Jagannath, The Saint Vincents Comprehensive Cancer Center, NY, NY
  • Dr. S. Vincent Rajkumar, Mayo Clinic, Rochester, MN
  • Moderator: Dr. Brian Durie, Cedars Sinai Comprehensive Cancer Center, Los Angeles, CA
    *denotes an IMF Scientific Advisor
The Agenda:
  • Introduction
Brian Durie, MD
Stan Winokur, MD
  • Multiple Myeloma-Initial Therapy
Vincent Rajkumar, MD
  • Myeloma in Remission-What Do You Do Next?
William Bensinger, MD
  • Myeloma – High Risk Disease
Raymond Alexanian, MD
  • Myeloma – With Complications of Therapy
Bart Barlogie, MD, PhD
  • Myeloma – The Role of Maintenance Therapy
Sundar Jagannath, MD
  • Myeloma – Appropriate Use of Bisphosphonates
Robert Kyle, MD
  • Myeloma - Relapse on Thalidomide
Vincent Rajkumar, MD
  • Myeloma - The Role of Bisphosphonates With No Bone Lesions
William Bensinger, MD
  • M-Spike – What Do You Tell The Patient?
Robert Kyle, MD
  • Waldenstrom’s Macroglobulinemia
Raymond Alexanian, MD
  • “Ask the Expert” Panel:

Vincent Rajkumar, MD William Bensinger, MD
Raymond Alexanian, MD
Bart Barlogie, MD, PhD
Sundar Jagannath, MD Robert Kyle, MD

This educational symposium is the result of a partnership between the Network for Oncology Communication and Research (NOCR) and the International Myeloma Foundation, and is sponsored by an unrestricted educational grant from the IMF.

A compilation synopsis will be published by the IMF immediately following the Challenging Cases meeting. The synopsis will include the actual cases presented, analysis and other highlights. The feedback and data presented at the Challenging Cases meeting will complement the manuscript on the Myeloma Treatment Guidelines drafted by the IMF Scientific Advisory Board, as well as draw attention to emerging trends in myeloma from practicing physicians across the country.